The Influence of Comorbidities, General Health Status, and Self-Care Self-Efficacy on COVID-19 Symptoms During the Omicron Wave.

CUREUS JOURNAL OF MEDICAL SCIENCE - Tập 15 Số 11 - Trang e49176 - 2023
Mini M Jose1, Juan Feng1, Hoang T Nguyen1, Cheryl Juneau1, Bushra M Manakatt1, Jennifer Barnett1, Jennifer L Jones1, Mukaila Raji2,3
1School of Nursing, University of Texas Medical Branch, Galveston, USA
2Department of Internal Medicine, Division of Geriatrics & Palliative Medicine, University of Texas Medical Branch, Galveston, USA.
3Department of Preventive Medicine and Population Health, University of Texas Medical Branch, Galveston, USA

Tóm tắt

Background The emergence of the less virulent COVID-19 strains such as Omicron and its subvariants shifted the paradigm of COVID-19 treatment from inpatient treatment to regular outpatient care. The individual health determinants affecting COVID-19 disease severity among vulnerable adults treated in outpatient settings are an under-researched area. Methods This study conducted in an outpatient COVID-19 antibody infusion center employed a cross-sectional survey design to explore the impact of comorbidities, general health status, and self-care self-efficacy on COVID-19 symptom severity. We recruited 120 COVID-19-positive participants over 40 years of age, of which 117 completed the study with 87 providing complete data. After the screening and consenting process, the participants completed the following surveys in a secure REDCap survey software (Vanderbilt University, Nashville, USA) on an iPad (Apple Inc., Cupertino, USA): 1) sociodemographic questionnaire, 2) Charlson Comorbidity Index (CCI) to capture comorbidities, 3) Medical Outcomes Study Short-Form (SF-12) to assess general health including physical (PCS) and mental (MCS) health subscales, 4) Self-Care Self-Efficacy Scale (SCSES) to measure self-care self-efficacy, and 5) the COVID-19 Symptom rating scale (COVID-19 SRS). Statistical analysis used were Chi-square and Pearson correlations. Results As evidenced by CCI, the top five comorbidities were hypertension (42%), diabetes mellitus (31%), pulmonary disease (19%), depression (14%), and solid tumors (11%). Age was statistically significantly correlated to comorbidity burden (p<0.0001). Severe COVID-19 symptoms reported were fatigue, myalgia, cough, runny nose, and sore throat. The general health status measure (SF-12) subscales showed that the patient's mental component summary (MCS) was more statistically significant to COVID-19 symptom severity than the physical component summary (PCS). The MCS demonstrated a statistically significant correlation with fatigue and myalgia (p<0.0001), headache and breathing difficulties (p<0.001), nausea/vomiting (p<0.01), and abdominal pain/diarrhea (p<0.05). The PCS showed a lesser statistically significant correlation with fatigue, myalgia, headaches (p<0.01), fever/chills, cough, congestion/runny nose, night sweats, breathing difficulties, nausea/vomiting, and abdominal pain/diarrhea (p<0.05). Interestingly, the 'loss of smell' which is the hallmark symptom of COVID-19 was the only symptom that showed a statically significant correlation with the Charlson Comorbidity Index (p<0.05), and it did not show any association with either mental (SF-12 MCS) or physical (SF-12 PCS) health status. The SF-12 MCS also showed a statistically significant correlation with a diagnosis of depression (p< 0.01), validating it as a true measure of mental health among vulnerable adults. The SCSES was not correlated with any of the COVID-19 symptoms. Conclusions The patient's general health status, especially mental health was more statistically significant to COVID-19 symptoms. The COVID-19 hallmark symptom of 'loss of smell' was the only symptom that showed statistical significance with comorbidities. Within the limitations of a cross-sectional survey design and convenient sampling methods, this study calls to tailor general health status, especially mental health, and cumulative comorbidity burden to risk assessment/risk stratification of COVID-19 care.

Từ khóa

#adults with covid-19 #charlson comorbidity index #covid-19 outpatient care #covid-19 symptom rating scale #depression and covid-19 #mental health and covid-19 #omicron #self-care self-efficacy scale #sf-12 #the covid-19 symptoms severity

Tài liệu tham khảo

Awareness of SARS-CoV-2 Omicron variant infection among adults with recent COVID-19 seropositivity. Joung SY, Ebinger JE, Sun N, et al. JAMA Netw Open. 2022;5:0.

Outpatient treatment of confirmed COVID-19: living, rapid practice points from the American College of Physicians (Version 1) Qaseem A, Yost J, Miller MC, et al. Ann Intern Med. 2023;176:115–124.

Recommendations for the outpatient drug treatment of patients with COVID-19. Kaduszkiewicz H, Kochen MM, Kluge S, Malin JJ, Weibel S, Skoetz N. Dtsch Arztebl Int. 2022;119:342–349.

Primary care relevant risk factors for adverse outcomes in patients with COVID-19 infection: a systematic review. Bentivegna M, Hulme C, Ebell MH. J Am Board Fam Med. 2021;34:0–26.

Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. Dessie ZG, Zewotir T. BMC Infect Dis. 2021;21:855.

Factors associated with prompt recovery among hospitalised patients with coronavirus disease 2019. Ny P, Kelsom C, Chron A, et al. Int J Clin Pract. 2021;75:0.

Predictors of adverse prognosis in COVID-19: a systematic review and meta-analysis. Figliozzi S, Masci PG, Ahmadi N, et al. Eur J Clin Invest. 2020;50:0.

The prognostic value of comorbidity for the severity of COVID-19: a systematic review and meta-analysis study. Fathi M, Vakili K, Sayehmiri F, Mohamadkhani A, Hajiesmaeili M, Rezaei-Tavirani M, Eilami O. PLoS One. 2021;16:0.

Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19. Rosenthal N, Cao Z, Gundrum J, Sianis J, Safo S. JAMA Netw Open. 2020;3:0.

Health-related quality of life mildly affected following COVID-19: a retrospective pre-post cohort study with a propensity score-matched control group. Lapin B, Katzan IL. J Gen Intern Med. 2022;37:862–869.

The Charlson comorbidity index can be used prospectively to identify patients who will incur high future costs. Charlson M, Wells MT, Ullman R, King F, Shmukler C. PLoS One. 2014;9:0.

Does the Charlson comorbidity index help predict the risk of death in COVID-19 patients? Comoglu S, Kant A. North Clin Istanb. 2022;9:117–121.

Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: a systematic review and meta-analysis. Khan MM, Khan MN, Mustagir MG, Rana J, Islam MS, Kabir MI. J Glob Health. 2020;10:20503.

Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:382–386.

Use of the SF-12 questionnaire to assess physical and mental health status in patients with psoriasis. Sampogna F, Mastroeni S, Pallotta S, Fusari R, Uras C, Napolitano M, Abeni D. J Dermatol. 2019;46:1153–1159.

[SARS CoV-2/COVID-19: evidence-based recommendation on diagnosis and therapy] Bein B, Bachmann M, Huggett S, Wegermann P. Anasthesiol Intensivmed Notfallmed Schmerzther. 2020;55:257–265.

Covid-19: "Steady the front line! There is no retreat from here". Muir G, Boff J. BMJ. 2020;369:0.

Development and psychometric testing of the self-care in COVID-19 (SCOVID) scale, an instrument for measuring self-care in the COVID-19 pandemic. De Maria M, Ferro F, Ausili D, et al. Int J Environ Res Public Health. 2020;17

Validity and reliability of the self-care activities screening scale (SASS-14) during COVID-19 lockdown. Martínez M, Luis EO, Oliveros EY, Fernández-Berrocal P, Sarrionandia A, Vidaurreta M, Bermejo-Martins E. Health Qual Life Outcomes. 2021;19:1.

A brief telephone severity scoring system and therapeutic living centers solved acute hospital-bed shortage during the COVID-19 outbreak in Daegu, Korea. Kim SW, Lee KS, Kim K, Lee JJ, Kim JY. J Korean Med Sci. 2020;35:0.

Development and validation a nomogram for predicting the risk of severe COVID-19: a multi-center study in Sichuan, China. Zhou Y, He Y, Yang H, et al. PLoS One. 2020;15:0.

COVID-19: risk accumulation among biologically and socially vulnerable older populations. Calderón-Larrañaga A, Dekhtyar S, Vetrano DL, Bellander T, Fratiglioni L. Ageing Res Rev. 2020;63:101149.

COVID-19: perceived infection risk and barriers to uptake of Pfizer-BioNTech and Moderna vaccines among community healthcare workers. Famuyiro TB, Ogunwale A, des Bordes J, Raji M. J Racial Ethn Health Disparities. 2022;9:1543–1549.

The REDCap consortium: building an international community of software platform partners. Harris PA, Taylor R, Minor BL, et al. J Biomed Inform. 2019;95:103208.

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. J Biomed Inform. 2009;42:377–381.

Age-related risk factors and severity of SARS-CoV-2 infection: a systematic review and meta-analysis. Rahman MM, Bhattacharjee B, Farhana Z, et al. J Prev Med Hyg. 2021;62:0–71.

Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Clark A, Jit M, Warren-Gash C, et al. Lancet Glob Health. 2020;8:0–17.

A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19. Thakur B, Dubey P, Benitez J, et al. Sci Rep. 2021;11:8562.

Trends in the use of benzodiazepines, Z-hypnotics, and serotonergic drugs among US women and men before and during the COVID-19 pandemic. Milani SA, Raji MA, Chen L, Kuo YF. JAMA Netw Open. 2021;4:0.

A systematic review and meta-analysis of 90 cohort studies of social isolation, loneliness and mortality. Wang F, Gao Y, Han Z, et al. Nat Hum Behav. 2023;7:1307–1319.

Thông tin
Thông tin xuất bản

CUREUS JOURNAL OF MEDICAL SCIENCE

Tập 15 Số 11

e49176

Thông tin tác giả